Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

about

Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

Item

http://www.wikidata.org/entity/Q58126050

description

article

@en

im August 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2012

@uk

name

Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

@en

Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

@nl

type

Item

label

Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

@en

Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

@nl

prefLabel

Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

@en

Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

@nl

P1476

Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

@en

P2093

George Wang

http://www.w3.org/2001/XMLSchema#string

Hongfang Wang

http://www.w3.org/2001/XMLSchema#string

Lijuan Qiu

http://www.w3.org/2001/XMLSchema#string

PeiPei Liu

http://www.w3.org/2001/XMLSchema#string

Pin Lv

http://www.w3.org/2001/XMLSchema#string

P2860

t10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in SKBr3 breast cancer cells: possible role of COX2.

Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.

Design, synthesis, and docking studies of peptidomimetics based on HER2-herceptin binding site with potential antiproliferative activity against breast cancer cell lines.

Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

Trastuzumab: triumphs and tribulations.

Structural alterations of the epidermal growth factor receptor gene in human gliomas

In vitro assays for the evaluation of drug resistance in tumor cells.

Development and characterization of a fully functional small anti-HER2 antibody.

Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimics.

P304

1590-1603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00032719.2012.677787

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime